Welcome to LookChem.com Sign In|Join Free

CAS

  • or

711028-98-7

Post Buying Request

711028-98-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

711028-98-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 711028-98-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,1,0,2 and 8 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 711028-98:
(8*7)+(7*1)+(6*1)+(5*0)+(4*2)+(3*8)+(2*9)+(1*8)=127
127 % 10 = 7
So 711028-98-7 is a valid CAS Registry Number.

711028-98-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2-bromoacetyl)pyrrolidin-2-one

1.2 Other means of identification

Product number -
Other names 1-(BROMOACETYL)-2-PYRROLIDINONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:711028-98-7 SDS

711028-98-7Relevant articles and documents

Identification of Small-Molecule Modulators of Diguanylate Cyclase by FRET-Based High-Throughput Screening

Christen, Matthias,Kamischke, Cassandra,Kulasekara, Hemantha D.,Olivas, Kathleen C.,Kulasekara, Bridget R.,Christen, Beat,Kline, Toni,Miller, Samuel I.

, p. 394 - 407 (2019/01/04)

The bacterial second messenger cyclic diguanosine monophosphate (c-di-GMP) is a key regulator of cellular motility, the cell cycle, and biofilm formation with its resultant antibiotic tolerance, which can make chronic infections difficult to treat. Therefore, diguanylate cyclases, which regulate the spatiotemporal production of c-di-GMP, might be attractive drug targets for control of biofilm formation that is part of chronic infections. We present a FRET-based biochemical high-throughput screening approach coupled with detailed structure–activity studies to identify synthetic small-molecule modulators of the diguanylate cyclase DgcA from Caulobacter crescentus. We identified a set of seven small molecules that regulate DgcA enzymatic activity in the low-micromolar range. Subsequent structure–activity studies on selected scaffolds revealed a remarkable diversity of modulatory behavior, including slight chemical substitutions that reverse the effects from allosteric enzyme inhibition to activation. The compounds identified represent new chemotypes and are potentially developable into chemical genetic tools for the dissection of c-di-GMP signaling networks and alteration of c-di-GMP-associated phenotypes. In sum, our studies underline the importance of detailed mechanism-of-action studies for inhibitors of c-di-GMP signaling and demonstrate the complex interplay between synthetic small molecules and the regulatory mechanisms that control the activity of diguanylate cyclases.

A convenient method for preparation of α-imino carboxylic acid derivatives and application to the asymmetric synthesis of unnatural α-amino acid derivative

Inokuma, Tsubasa,Jichu, Takahisa,Nishida, Kodai,Shigenaga, Akira,Otaka, Akira

, p. 573 - 581 (2019/12/26)

We describe herein a manganese(IV) oxide-mediated oxidation of N-p-methoxyphenyl (PMP)-protected glycine derivatives for the synthesis of α-imino carboxylic acid derivatives. Using this methodology, utilization of unstable glyoxic acid derivatives was avo

Application of enantioselective radical reactions: Synthesis of (+)-ricciocarpins A and B

Sibi, Mukund P.,He, Liwen

, p. 1749 - 1752 (2007/10/03)

Matrix presented. Enantioselective synthesis of (+)-ricciocarpins A and B has been achieved in 41 and 45% overall yields, respectively, starting from a β-substituted oxazolidinone. The key steps in the strategy are an enantioselective conjugate radical ad

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 711028-98-7